1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. NEUROREHABILITATION MARKET BY PRODUCT
5.1. Introduction
5.2. Neuro-Robotic System
5.3. Wearable Devices
5.4. Brain Computer Interface
5.5. Non-Invasive Stimulators
5.6. Neuronal Prosthetics
5.7. Others
6. NEUROREHABILITATION MARKET BY APPLICATION
6.1. Introduction
6.2. Stroke
6.3. Traumatic Brain Injury (TBI)
6.4. Spinal Cord Injury (SCI)
6.5. Parkinson's Disease
6.6. Cerebral Palsy
6.7. Others
7. NEUROREHABILITATION MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Rehabilitation Centers
7.5. Home Care Settings
8. NEUROREHABILITATION MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medtronic plc
10.2. Abbott Laboratories
10.3. Bionik Laboratories Corp.
10.4. Ekso Bionics Holdings, Inc.
10.5. DIH Medical Group
10.6. ReWalk Robotics
10.7. BioXtreme Ltd.
10.8. Kinova
10.9. Saebo Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES